This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
Rankings published in 2026
Tier 1
Tier 2
Tier 3
Notable
Tier 1
Tier 2
Tier 3
Notable
Tier 1
Tier 2
Tier 3
Tier 4
Notable
Tier 1
Tier 2
Tier 3
Notable
Linked Reviews
Financial and corporate
Established in 2016 in Beijing, Shihui Partners is an emerging boutique law firm in China.
Focusses / specialisms
The firm provides specialist advice in M&A, private equity, capital markets and investment funds, and has achieved many results in the new economy industry.
Key clients
Key clients of Shihui include Orchid Asia Investment Fund, JD.com, JD Health Group, Lightspeed Venture Capital, CICC Capital, Ping An Insurance, ZZ Capital, East West Bank of China and Legend Capital.
Research period review: 33rd edition (2022/2023)
In 2022, Shihui Partners represented JD Property Group Corporation on its $800 million of Series B preferred stock financing project; advised PICC Investment for its investment in the private equity financing of CEC GienTech digital technology group with the total financing amount of more than Rmb2.5 billion. Key names to note in the firm’s PE side are George Niu and Miranda Jiang.
On capital markets side, the firm completed an A-Share IPO of Shanghai MicroPort EP MedTech, which made the client become the first company in the medical device industry who completed the IPO on the STAR Market under the fifth set of criteria and is the only domestic manufacturer that can provide complete solutions for cardiac electrophysiology equipment and consumables to both the domestic and international markets. Besides that, the firm is also handling a few ongoing IPOs.
In 2021, the firm represented Beijing Jingdong Century Trade in its public offering of Rmb1.5 billion short-term corporate bonds and issuance of Rmb10 billion registered private placement notes.
Last year, the firm hired Jing Lu from Sidley Austin to strengthen its data compliance and anti-bribery compliance and Zhenxing Mai from Jeffrey Mak Law Firm to work on corporate finance. The firm lost partner Yan Xia who specialises at investment and financing.
Deal highlights: 33rd edition (2022/2023)
Shanghai MicroPort EP MedTech’s A-share IPO.
Henan Zhang Zhongjing Pharmacy’s A-share IPO.
Synfuels China’s A-share IPO.
Hypower Microelectronics’ A-share IPO.
JD Property Group Corporation’s $800 million Series B preferred stock financing.
Client feedback: 33rd edition (2022/2023)
Capital markets
“Very responsive and professional. Efficient and smart.”
Private equity
“The quality of the documents is good, basically reassuring to customers. Feedback is fast and positive. Clients can actively communicate to meet the customer's requirements.”
M&A
“Detailed work and timely replies and comments reduces the workload for us.”
Lawyer feedback: 33rd edition (2022/2023)
Xin Xie
“Very responsive and diligent. Will always find time to meet the deadlines of projects and provides useful feedback or comments.”
Xiaochen Zhang
“Great team leader able to provide the relevant resources needed for various types of projects that we inquire about with them.”
Jian Zhang
“Quick response, proactive and problem-solving, very professional and responsible.”
Liang Zhao
“Very good at communication, very innovative thinking, good at coming up with some solutions to problems. He has all-round ability.”
